A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Clinical trial NCT06659640 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06659640
- Sponsor
- Alnylam Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2028-01-05
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.